ACHL

Achilles Therapeutics plc American Depositary Shares
ACHL

Overview Fund Activity
Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

25 hedge funds and large institutions have $101M invested in Achilles Therapeutics plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-5
Holders Change %
-16.67%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
8
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
$4.41M
2
BlackRock
BlackRock
New York
$784K
3
Bank of America
Bank of America
North Carolina
$31K
4
Renaissance Technologies
Renaissance Technologies
New York
$90K
5
Geode Capital Management
Geode Capital Management
Massachusetts
$63K

Top Sellers

1
PA
Perceptive Advisors
New York
$0
2
RG
Redmile Group
California
$4.73M
3
WP
Woodline Partners
California
$715K
4
SCP
Sender Company & Partners
New York
$0
5
Millennium Management
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RI
26
RTW Investments
New York
– -$61K -12,229 Closed
JF
27
Jump Financial
Illinois
– -$55K -11,000 Closed
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
– -$5K -1,000 Closed
1
2